Change search
ReferencesLink to record
Permanent link

Direct link
Metabolomic screening of pre-diagnostic serum samples identifies association between alpha- and gamma-tocopherols and glioblastoma risk
Umeå University, Faculty of Science and Technology, Department of Chemistry.
Umeå University, Faculty of Medicine, Department of Radiation Sciences, Oncology.
Umeå University, Faculty of Science and Technology, Department of Chemistry.
Umeå University, Faculty of Science and Technology, Department of Chemistry.
Show others and affiliations
2016 (English)In: OncoTarget, ISSN 1949-2553, E-ISSN 1949-2553, Vol. 7, no 24, 37043-37053 p.Article in journal (Refereed) PublishedText
Abstract [en]

Glioblastoma is associated with poor prognosis with a median survival of one year. High doses of ionizing radiation is the only established exogenous risk factor. To explore new potential biological risk factors for glioblastoma, we investigated alterations in metabolite concentrations in pre-diagnosed serum samples from glioblastoma patients diagnosed up to 22 years after sample collection, and undiseased controls. The study points out a latent biomarker for future glioblastoma consisting of nine metabolites (gamma-tocopherol, alpha-tocopherol, erythritol, erythronic acid, myo-inositol, cystine, 2-keto-L-gluconic acid, hypoxanthine and xanthine) involved in antioxidant metabolism. We detected significantly higher serum concentrations of alpha-tocopherol (p=0.0018) and gamma-tocopherol (p=0.0009) in future glioblastoma cases. Compared to their matched controls, the cases showed a significant average fold increase of alpha- and gamma-tocopherol levels: 1.2 for alpha-T (p=0.018) and 1.6 for gamma-T (p=0.003). These tocopherol levels were associated with a glioblastoma odds ratio of 1.7 (alpha-T, 95% CI: 1.0-3.0) and 2.1 (gamma-T, 95% CI: 1.2-3.8). Our exploratory metabolomics study detected elevated serum levels of a panel of molecules with antioxidant properties as well as oxidative stress generated compounds. Additional studies are necessary to confirm the association between the observed serum metabolite pattern and future glioblastoma development.

Place, publisher, year, edition, pages
2016. Vol. 7, no 24, 37043-37053 p.
Keyword [en]
population-based, serum metabolite, vitamin E, antioxidants, brain tumor
National Category
Cancer and Oncology
Identifiers
URN: urn:nbn:se:umu:diva-123973DOI: 10.18632/oncotarget.9242ISI: 000377756800119OAI: oai:DiVA.org:umu-123973DiVA: diva2:1046899
Available from: 2016-11-15 Created: 2016-07-07 Last updated: 2016-11-15Bibliographically approved

Open Access in DiVA

fulltext(2247 kB)21 downloads
File information
File name FULLTEXT01.pdfFile size 2247 kBChecksum SHA-512
22385a1b13ef42b8326cabf1d0bb3fd0c84095249973b7fdd56462b8f7f75d9334c6546b4acb0fbbaafdf2f50cf9286d0aa321a195ea01a7252517196eb1e280
Type fulltextMimetype application/pdf

Other links

Publisher's full text

Search in DiVA

By author/editor
Björkblom, BennyWibom, CarlJonsson, PärMörén, LinaAndersson, UlrikaAntti, HenrikMelin, Beatrice
By organisation
Department of ChemistryOncology
In the same journal
OncoTarget
Cancer and Oncology

Search outside of DiVA

GoogleGoogle Scholar
Total: 21 downloads
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

Altmetric score

Total: 153 hits
ReferencesLink to record
Permanent link

Direct link